AstraZeneca has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical Research and ...

Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...

CompanyOverview|NASDAQ:CLLS] Cellectis S.A. (NASDAQ: CLLS) is a clinical-stage biotechnology company focused on developing ...

Two years ago, the Pharmaceutical Research and Manufacturers of America (PhRMA) trade group faced a mini-exodus as several ...

AstraZeneca PLC ADR closed 22.59% below its 52-week high of $87.68, which the company achieved on August 30th.

Analysts at Leerink Partners said in a Monday note that DESTIN-Breast09’s findings “could support an approval” for Enhertu in ...

Astra said a trial of its Enhertu treatment showed the drug demonstrated a 'highly statistically significant' improvement on ...

Our writer celebrates being average and looks at one FTSE 100 stock that could help investors navigate their way through the minefield of Trump’s tariffs.

More than 300 people are currently being recruited for the testing of a no-needle COVID-19 vaccine that’s made in Hamilton.

As the US government moves to curb academic freedoms, David Uwakwe gives the lowdown on Spain’s moves to welcome those ...

Roche has pledged to build a giant weight-loss drug factory in the US. The plans form part of a $50bn (£37bn) pledge aimed at ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a new study.